PENNYBUSTER'S PENNY BUSTIN PLAYS!!

[Pennybuster]

$PPHM .88 recent news/filings

## source: finance.yahoo.com

Thu, 28 Jan 2016 13:00:00 GMT ~ OncBioMune Patents a New Promising Approach to Chemotherapy

[Accesswire] - REDONDO BEACH, CA / ACCESSWIRE / January 28, 2016 / Chemotherapy compounds like paclitaxel and docetaxel have been used for years to treat cancer, but the caveat is that they indiscriminately kill both ...

read full: http://finance.yahoo.com/news/oncbiomune-patents-promising-approach-chemotherapy-130000708.html
*********************************************************

Fri, 22 Jan 2016 13:43:01 GMT ~ Peregrine Pharma (PPHM): Strong Industry, Solid Earnings Estimate Revisions


read full: http://finance.yahoo.com/news/peregrine-pharma-pphm-strong-industry-134301076.html
*********************************************************

Wed, 20 Jan 2016 13:15:04 GMT ~ Peregrine Pharmaceuticals to Present at Two Upcoming Cancer Immunotherapy Conferences

[at noodls] - January 20, 2016 , (GLOBE NEWSWIRE) -- (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer, today announced ...

read full: http://www.noodls.com/view/54AB85CB526DE9620E8A29DFF8906D0F7180B4CC
*********************************************************

Wed, 20 Jan 2016 13:05:00 GMT ~ Peregrine Pharmaceuticals to Present at Two Upcoming Cancer Immunotherapy Conferences

[GlobeNewswire] - TUSTIN, Calif., Jan. 20, 2016-- Peregrine Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer, today announced that ...

read full: http://finance.yahoo.com/news/peregrine-pharmaceuticals-present-two-upcoming-130500149.html
*********************************************************

Mon, 11 Jan 2016 13:18:05 GMT ~ Peregrine Pharmaceuticals Provides Update on Planned Expansion of Bavituximab Clinical Program in Lung, Breast and Other Cancers

[at noodls] - January 11, 2016 -- Phase II Study in NSCLC in Collaboration with AstraZeneca Evaluating Bavituximab Plus Durvalumab to Expand Lung Cancer Program in Q1 2016 -- -- Phase II/III Study in HER2-Negative Metastatic ...

read full: http://www.noodls.com/view/0E5E802EFBC4E304C0A33409F15023544199CCEE
*********************************************************

$PPHM charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PPHM company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PPHM/company-info
Ticker: $PPHM
OTC Market Place: Not Available
CIK code: 0000704562
Company name: Peregrine Pharmaceuticals, Inc.
Company website: http://www.techniclone.com
Incorporated In: DE, USA

Business Description: OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com (window.NREUM||(NREUM={})).loader_config={xpid:"UwMGWVdSGwQIU1RQAgQ="};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;oc;c++)a[c].apply(i,r);return i}function c(t,e){d[t]=f(t).concat(e)}function f(t){return d[t]||[]}function u(){return r(s)}var d={};return{on:c,emit:s,create:u,listeners:f,context:e,_events:d}}function o(){return new n}var i="nr@context",a=t("gos");e.exports=r()},{gos:"7eSDFh"}],ee:[function(t,e){e.exports=t("QJf3ax")},{}],3:[function(t){function e(t){try{i.console&&console.log(t)}catch(e){}}var n,r=t("ee"),o=t(1),i={};try{n=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(i.console=!0,-1!==n.indexOf("dev")&&(i.dev=!0),-1!==n.indexOf("nr_dev")&&(i.nrDev=!0))}catch(a){}i.nrDev&&r.on("internal-error",function(t){e(t.stack)}),i.dev&&r.on("fn-err",function(t,n,r){e(r.stack)}),i.dev&&(e("NR AGENT IN DEVELOPMENT MODE"),e("flags: "+o(i,function(t){return t}).join(", ")))},{1:25,ee:"QJf3ax"}],4:[function(t){function e(t,e,n,i,a){try{f?f-=1:r("err",[a||new UncaughtException(t,e,n)])}catch(c){try{r("ierr",[c,(new Date).getTime(),!0])}catch(u){}}return"function"==typeof s?s.apply(this,o(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function n(t){r("err",[t,(new Date).getTime()])}var r=t("handle"),o=t(6),i=t("ee"),a=t("loader"),s=window.onerror,c=!1,f=0;a.features.err=!0,t(5),window.onerror=e;try{throw new Error}catch(u){"stack"in u&&(t(1),t(2),"addEventListener"in window&&t(3),a.xhrWrappable&&t(4),c=!0)}i.on("fn-start",function(){c&&(f+=1)}),i.on("fn-err",function(t,e,r){c&&(this.thrown=!0,n(r))}),i.on("fn-end",function(){c&&!this.thrown&&f>0&&(f-=1)}),i.on("internal-error",function(t){r("ierr",[t,(new Date).getTime(),!0])})},{1:11,2:10,3:8,4:12,5:3,6:26,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],5:[function(t){if(window.addEventListener){var e=t("handle"),n=t("ee");t(1),window.addEventListener("click",function(){e("inc",["ck"])},!1),window.addEventListener("hashchange",function(){e("inc",["hc"])},!1),n.on("pushState-start",function(){e("inc",["ps"])})}},{1:9,ee:"QJf3ax",handle:"D5DuLP"}],6:[function(t){t("loader").features.ins=!0},{loader:"G9z0Bl"}],7:[function(t){function e(){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var n=t("ee"),r=t("handle"),o=t(1),i=t(2);t("loader").features.stn=!0,t(3);var a=Event;n.on("fn-start",function(t){var e=t[0];e instanceof a&&(this.bstStart=Date.now())}),n.on("fn-end",function(t,e){var n=t[0];n instanceof a&&r("bst",[n,e,this.bstStart,Date.now()])}),o.on("fn-start",function(t,e,n){this.bstStart=Date.now(),this.bstType=n}),o.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),this.bstType])}),i.on("fn-start",function(){this.bstStart=Date.now()}),i.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),"requestAnimationFrame"])}),n.on("pushState-start",function(){this.time=Date.now(),this.startPath=location.pathname+location.hash}),n.on("pushState-end",function(){r("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),"addEventListener"in window.performance&&(window.performance.clearResourceTimings?window.performance.addEventListener("resourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.clearResourceTimings()},!1):window.performance.addEventListener("webkitresourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.webkitClearResourceTimings()},!1)),document.addEventListener("scroll",e,!1),document.addEventListener("keypress",e,!1),document.addEventListener("click",e,!1)}},{1:11,2:10,3:9,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],8:[function(t,e){function n(t){for(var e=t;e&&!e.hasOwnProperty("addEventListener");)e=Object.getPrototypeOf(e);e&&r(e)}function r(t){a.inPlace(t,["addEventListener","removeEventListener"],"-",o)}function o(t){return t[1]}var i=t("ee").create(),a=t(1)(i),s=t("gos");e.exports=i,r(window),"getPrototypeOf"in Object?(n(document),n(XMLHttpRequest.prototype)):XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&r(XMLHttpRequest.prototype),i.on("addEventListener-start",function(t){if(t[1]){var e=t[1];if("function"==typeof e){var n=s(e,"nr@wrapped",function(){return a(e,"fn-",null,e.name||"anonymous")});this.wrapped=t[1]=n}else"function"==typeof e.handleEvent&&a.inPlace(e,["handleEvent"],"fn-")}}),i.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:27,ee:"QJf3ax",gos:"7eSDFh"}],9:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window.history,["pushState","replaceState"],"-")},{1:27,ee:"QJf3ax"}],10:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=r(t[0],"fn-")})},{1:27,ee:"QJf3ax"}],11:[function(t,e){function n(t,e,n){t[0]=i(t[0],"fn-",null,n)}function r(t,e,n){this.method=n,this.timerDuration="number"==typeof t[1]?t[1]:0,t[0]=i(t[0],"fn-",this,n)}var o=t("ee").create(),i=t(1)(o);e.exports=o,i.inPlace(window,["setTimeout","setImmediate"],"setTimer-"),i.inPlace(window,["setInterval"],"setInterval-"),i.inPlace(window,["clearTimeout","clearImmediate"],"clearTimeout-"),o.on("setInterval-start",n),o.on("setTimer-start",r)},{1:27,ee:"QJf3ax"}],12:[function(t,e){function n(){f.inPlace(this,l,"fn-",o)}function r(t,e){f.inPlace(e,["onreadystatechange"],"fn-",o)}function o(t,e){return e}function i(t,e){for(var n in t)e[n]=t[n];return e}var a=t("ee").create(),s=t(1),c=t(2),f=c(a),u=c(s),d=window.XMLHttpRequest,l=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];e.exports=a,window.XMLHttpRequest=function(t){var e=new d(t);try{a.emit("new-xhr",[e],e),e.hasOwnProperty("addEventListener")&&u.inPlace(e,["addEventListener","removeEventListener"],"-",o),e.addEventListener("readystatechange",n,!1)}catch(r){try{a.emit("internal-error",[r])}catch(i){}}return e},i(d,XMLHttpRequest),XMLHttpRequest.prototype=d.prototype,f.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",o),a.on("send-xhr-start",r),a.on("open-xhr-start",r)},{1:8,2:27,ee:"QJf3ax"}],13:[function(t){function e(t){var e=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;u>o;o++)t.removeEventListener(f[o],this.listener,!1);if(!e.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){e.status=t.status;var i=this.lastSize||n(t);if(i&&(r.rxSize=i),this.sameOrigin){var s=t.getResponseHeader("X-NewRelic-App-Data");s&&(e.cat=s.split(", ").pop())}}else e.status=0;r.cbTime=this.cbTime,c.emit("xhr-done",[t],t),a("xhr",[e,r,this.startTime])}}}function n(t){var e=t.responseType,n="arraybuffer"===e||"blob"===e||"json"===e?t.response:t.responseText;return r(n)}function r(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}var i=t("loader");if(i.xhrWrappable){var a=t("handle"),s=t(2),c=t("ee"),f=["load","error","abort","timeout"],u=f.length,d=t(1),l=t(3),p=window.XMLHttpRequest;i.features.xhr=!0,t(5),t(4),c.on("new-xhr",function(t){var n=this;n.totalCbs=0,n.called=0,n.cbTime=0,n.end=e,n.ended=!1,n.xhrGuids={},n.lastSize=0,l&&(l>34||10>l)||window.opera||t.addEventListener("progress",function(t){n.lastSize=t.loaded},!1)}),c.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),c.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),c.on("send-xhr-start",function(t,e){var n=this.metrics,o=t[0],i=this;if(n&&o){var a=r(o);a&&(n.txSize=a)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof e.onload))&&i.end(e)}catch(n){try{c.emit("internal-error",[n])}catch(r){}}};for(var s=0;u>s;s++)e.addEventListener(f[s],this.listener,!1)}),c.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),c.on("xhr-load-added",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),c.on("xhr-load-removed",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),c.on("addEventListener-end",function(t,e){e instanceof p&&"load"===t[0]&&c.emit("xhr-load-added",[t[1],t[2]],e)}),c.on("removeEventListener-end",function(t,e){e instanceof p&&"load"===t[0]&&c.emit("xhr-load-removed",[t[1],t[2]],e)}),c.on("fn-start",function(t,e,n){e instanceof p&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),c.on("fn-end",function(t,e){this.xhrCbStart&&c.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}},{1:"XL7HBI",2:14,3:16,4:12,5:8,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],14:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!e.protocol||":"===e.protocol||e.protocol===n.protocol,a=e.hostname===document.domain&&e.port===n.port;return r.sameOrigin=i&&(!e.hostname||a),r}},{}],15:[function(t,e){function n(t){return function(){r(t,[(new Date).getTime()].concat(i(arguments)))}}var r=t("handle"),o=t(1),i=t(2);"undefined"==typeof window.newrelic&&(newrelic=window.NREUM);var a=["setPageViewName","addPageAction","setCustomAttribute","finished","addToTrace","inlineHit","noticeError"];o(a,function(t,e){window.NREUM[e]=n("api-"+e)}),e.exports=window.NREUM},{1:25,2:26,handle:"D5DuLP"}],16:[function(t,e){var n=0,r=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);r&&(n=+r[1]),e.exports=n},{}],gos:[function(t,e){e.exports=t("7eSDFh")},{}],"7eSDFh":[function(t,e){function n(t,e,n){if(r.call(t,e))return t[e];var o=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:o,writable:!0,enumerable:!1}),o}catch(i){}return t[e]=o,o}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],D5DuLP:[function(t,e){function n(t,e,n){return r.listeners(t).length?r.emit(t,e,n):void(r.q&&(r.q[t]||(r.q[t]=[]),r.q[t].push(e)))}var r=t("ee").create();e.exports=n,n.ee=r,r.q={}},{ee:"QJf3ax"}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],XL7HBI:[function(t,e){function n(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:i(t,o,function(){return r++})}var r=1,o="nr@id",i=t("gos");e.exports=n},{gos:"7eSDFh"}],id:[function(t,e){e.exports=t("XL7HBI")},{}],G9z0Bl:[function(t,e){function n(){if(!h++){var t=p.info=NREUM.info,e=f.getElementsByTagName("script")[0];if(t&&t.licenseKey&&t.applicationID&&e){s(d,function(e,n){t[e]||(t[e]=n)});var n="https"===u.split(":")[0]||t.sslForHttp;p.proto=n?"https://":"http://",a("mark",["onload",i()]);var r=f.createElement("script");r.src=p.proto+t.agent,e.parentNode.insertBefore(r,e)}}}function r(){"complete"===f.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=t(1),c=window,f=c.document;t(2);var u=(""+location).split("?")[0],d={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-852.min.js"},l=window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent),p=e.exports={offset:i(),origin:u,features:{},xhrWrappable:l};f.addEventListener?(f.addEventListener("DOMContentLoaded",o,!1),c.addEventListener("load",n,!1)):(f.attachEvent("onreadystatechange",r),c.attachEvent("onload",n)),a("mark",["firstbyte",i()]);var h=0},{1:25,2:15,handle:"D5DuLP"}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],25:[function(t,e){function n(t,e){var n=[],o="",i=0;for(o in t)r.call(t,o)&&(n=e(o,t[o]),i+=1);return n}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],26:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r

$PPHM share structure

## source: otcmarkets.com

Market Value: $199,817,603 a/o Feb 05, 2016
Shares Outstanding: 229,701,808 a/o Dec 09, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$PPHM extra dd links

Company name: Peregrine Pharmaceuticals, Inc.
Company website: http://www.techniclone.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PPHM+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PPHM+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PPHM+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PPHM/news - http://finance.yahoo.com/q/h?s=PPHM+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PPHM/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PPHM/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PPHM+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PPHM
DTCC (dtcc.com): http://search2.dtcc.com/?q=Peregrine+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Peregrine+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Peregrine+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.techniclone.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.techniclone.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.techniclone.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PPHM
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000704562&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PPHM/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PPHM/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PPHM&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PPHM
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PPHM/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PPHM+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PPHM+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PPHM
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PPHM
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PPHM+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PPHM/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PPHM+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PPHM.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PPHM
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PPHM/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PPHM/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PPHM
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PPHM
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PPHM:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PPHM
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PPHM



$PPHM DD Notes ~ http://www.ddnotesmaker.com/PPHM